FASTFX TAB - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
86471455
Word Mark
FASTFX TAB
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2016-02-15
Filing Date
2014-12-04
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2015-05-19
Attorney Name
Law Office Assigned Location Code
M50
Employee Name
FIRST, VIVIAN M
Statements
Disclaimer with Predetermined Text
"TAB"
Goods and Services
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Sleeping pills/tablets; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient
Pseudo Mark
FAST FIX TAB
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2014-12-11
Primary Code
005
Correspondences
Name
RUSSELL BLAYMORE
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2014-12-08 | NEW APPLICATION ENTERED IN TRAM |
2014-12-11 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2014-12-12 | NOTICE OF PSEUDO MARK E-MAILED |
2015-03-19 | ASSIGNED TO EXAMINER |
2015-03-19 | EXAMINERS AMENDMENT -WRITTEN |
2015-03-19 | EXAMINERS AMENDMENT E-MAILED |
2015-03-19 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2015-03-19 | EXAMINER'S AMENDMENT ENTERED |
2015-03-19 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2015-04-10 | ASSIGNED TO LIE |
2015-04-10 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2015-04-29 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2015-05-19 | PUBLISHED FOR OPPOSITION |
2015-05-19 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2015-07-14 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2016-02-15 | ABANDONMENT - NO USE STATEMENT FILED |
2016-02-16 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |